- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06736210
The Role of Extrinsic Foot Muscles Chances in Determining the Risk of Diabetic Foot Ulcer
The Role of Muscle Elastic Properties of Extrinsic Foot Muscles, Muscle Oxygenation and Plantar Pressure Change in Determining Diabetic Foot Ulcer Risk
Study Overview
Status
Conditions
Detailed Description
Recent guidelines for the treatment and prevention of diabetic foot complications emphasize the management/control of diabetes, foot care, patient education and self-management of foot care . Other rehabilitation approaches, including exercise therapy, have recently come to the forefront in the literature within the scope of preventive treatments. Exercises have been shown to be beneficial in diabetic patients, especially in increasing nerve velocity conduction in the lower extremities . As a result of these recommendations, evaluation of the risk of diabetic foot ulceration before ulceration develops, detailed analysis of all tissues and systems expected to be affected may be solved with preventive strategies by reducing the need for treatment.
The change in plantar pressure distribution in patients with diabetes is one of the mechanisms that form the basis of the mechanisms of foot ulcer formation. Altered biomechanical structure, high intensity and repetitive diffuse pressure due to neuropathy, and insufficiency of vascular tissues caused by peripheral arterial disease directly affect the plantar pressure distribution . Determining this change before diabetic wound formation, analyzing the changing plantar pressure ratios and determining the condition in the presence of neuropathy may improve the quality of the treatment program to be created.
In the study conducted by Stephens et al. In the study conducted by Stephens et al. the plantar surface tissue of the intrinsic foot muscles oxidized following exercise interventions in patients diagnosed with diabetes mellitus.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Uskudar
-
İ̇stanbul, Uskudar, Turkey, 34668
- University of Health Sciences Physical Therapy and Rehabilitation Lab
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria for Patients with Diabetes:
- Willingness to participate in the study
- Absence of current or past diabetic foot ulcers
- Classification within the 0 or 1 categories of the IWGDF classification system
Inclusion Criteria for Sedentary Healthy Participants:
- Willingness to participate in the study
- Not engaging in active sports activities
- Absence of current or past foot ulcers
Exclusion Criteria for all group:
- Presence of orthopedic, musculoskeletal, vestibular, visual, or neurological problems affecting mobility (other than DPN)
- History of prior orthopedic surgical intervention in the lower extremity
- Dementia or inability to provide consistent information
- Presence of major vascular complications (venous or arterial ulcers)
- Diagnosis of PAH (Peripheral Arterial Hypertension)
- Presence of plantar ulcers during or prior to the assessment
- Inability to walk independently without pain or assistive devices
- Illiteracy
- Presence of any foot deformity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Health Control Group
The healthy control group consisted of 10 participants with no history of foot or ankle injuries or systemic diseases, ensuring a baseline for comparison.
Assessments included isokinetic testing for plantar flexor (PF) and dorsiflexor (DF) muscle strength and endurance at angular velocities of 30°/s and 120°/s, respectively.
Additionally, functional evaluations such as the physical performance (heel-rise) test and patient-reported outcome measures (AOFAS and FAOS scores) were conducted.
These evaluations provided a comprehensive understanding of muscle performance and functional status in healthy individuals, serving as a reference point for interpreting deviations observed in the Lisfranc injury group.
|
Using the MyotonPro device, the elastic properties, including stiffness, elasticity, and tone, were evaluated for the tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, and peroneus longus muscles.
Measurements were performed in a controlled laboratory setting.
Muscle oxygenation levels were measured before and after a standardized exercise protocol using the MOXY device.
The exercise protocol consisted of a light-intensity dynamic task tailored to minimize fatigue and mimic functional activity.
Plantar pressure was assessed both statically and dynamically using a pressure-mapping platform.
This provided data on pressure distribution, contact times, and high-pressure areas across the foot during various conditions.
|
|
Experimental: IWDGF-0
The IWGDF 0 group included 10 patients classified as having no immediate risk for diabetic foot ulcers.
Assessments focused on evaluating the biomechanical and functional parameters of extrinsic foot muscles.
Muscle elasticity and dynamic stiffness were measured using the MyotonPro device, while muscle oxygenation levels (SmO2) were recorded pre- and post-exercise using the MOXY device.
Plantar pressure analysis was performed under both static and dynamic conditions to identify subtle variations in pressure distribution and foot biomechanics.
These evaluations aimed to detect early indicators of potential foot complications, even in patients without apparent risk, providing critical data for preventive strategies.
|
Using the MyotonPro device, the elastic properties, including stiffness, elasticity, and tone, were evaluated for the tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, and peroneus longus muscles.
Measurements were performed in a controlled laboratory setting.
Muscle oxygenation levels were measured before and after a standardized exercise protocol using the MOXY device.
The exercise protocol consisted of a light-intensity dynamic task tailored to minimize fatigue and mimic functional activity.
Plantar pressure was assessed both statically and dynamically using a pressure-mapping platform.
This provided data on pressure distribution, contact times, and high-pressure areas across the foot during various conditions.
|
|
Experimental: IWDGF-1
The IWGDF 1 group comprised 10 patients identified as having low risk for diabetic foot ulcers.
Comprehensive assessments were conducted to evaluate the biomechanical and functional properties of their extrinsic foot muscles.
Elasticity and dynamic stiffness of the tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, and peroneus longus muscles were measured using the MyotonPro device.
Muscle oxygenation levels (SmO2) were monitored pre- and post-exercise using the MOXY device to determine oxygen utilization and recovery capacity.
Additionally, plantar pressure was analyzed under static and dynamic conditions to assess changes in pressure distribution and foot biomechanics.
These detailed evaluations highlighted early biomechanical and functional changes, emphasizing the importance of targeted interventions in this low-risk group to prevent progression to higher risk categories.
|
Using the MyotonPro device, the elastic properties, including stiffness, elasticity, and tone, were evaluated for the tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, and peroneus longus muscles.
Measurements were performed in a controlled laboratory setting.
Muscle oxygenation levels were measured before and after a standardized exercise protocol using the MOXY device.
The exercise protocol consisted of a light-intensity dynamic task tailored to minimize fatigue and mimic functional activity.
Plantar pressure was assessed both statically and dynamically using a pressure-mapping platform.
This provided data on pressure distribution, contact times, and high-pressure areas across the foot during various conditions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle Elastic Properties
Time Frame: Measured within a 1-month period.
|
Stiffness, elasticity, and tone of the tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, and peroneus longus muscles measured using the MyotonPro device. Key Metrics: Differences in muscle stiffness, tone, and elasticity between groups. |
Measured within a 1-month period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle Oxygenation (SmO2)
Time Frame: Measured within a 1-month period.
|
Changes in local oxygen saturation (SmO2) levels of the targeted muscles, measured pre- and post-exercise using the MOXY device. Comparison of SmO2 levels between IWGDF 0, IWGDF 1, and healthy control groups. Key Metrics: Reduction in SmO2 levels and recovery trends post-exercise |
Measured within a 1-month period.
|
|
Plantar Pressure Parameters
Time Frame: Measured within a 1-month period.
|
Static and dynamic plantar pressure analysis to identify high-pressure regions and foot loading patterns. Key Metrics: Average plantar pressure values in midfoot and forefoot regions. Contact times and pressure distribution in dynamic gait analysis. |
Measured within a 1-month period.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Integration
Time Frame: Measured within a 1-month period.
|
Evaluation of the relationship between plantar pressure patterns and muscle biomechanical properties across all groups.
|
Measured within a 1-month period.
|
Collaborators and Investigators
Investigators
- Study Director: Defne KAYA UTLU, PhD, Saglik Bilimleri Universitesi
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SBU-FTR-AI-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and Digestive...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
Leiden University Medical CenterAndaluz Health ServiceCompletedDiabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes MellitusNetherlands, Spain
Clinical Trials on Muscle Elastic Properties Measurement
-
Assistance Publique Hopitaux De MarseilleUnknownAcute Type A DissectionFrance
-
Aston UniversitySandwell & West Birmingham Hospitals NHS TrustWithdrawn
-
University of ZurichUnknown
-
University Hospital, GrenobleCompletedAsthma | Cystic Fibrosis | COPDFrance
-
Kars State HospitalCompletedMuscle Weakness | Myofascial Pain SyndromeTurkey
-
Cambridge University Hospitals NHS Foundation TrustUnknownFemoroacetabular Impingement
-
Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie...CompletedMuscle Weakness | Muscle Weakness Condition | CopdRomania
-
Namik Kemal UniversityNot yet recruiting
-
Dilara Ekici ZincirciCompletedFibromyalgia | Muscle Strength | Force Measurement | IsokineticTurkey